Stony Brook University
Clinical trials sponsored by Stony Brook University, explained in plain language.
-
Herbal mouthwash takes on chlorhexidine in gum disease showdown
Disease control CompletedThis completed study tested whether a new herbal mouthwash and gel (StellaLife) works as well as the standard chlorhexidine mouthwash for treating gingivitis (early gum disease). 34 healthy adults without gum disease took part. The goal was to see if StellaLife can control plaque…
Phase: PHASE4 • Sponsor: Stony Brook University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New nerve block may ease kidney stone pain faster
Symptom relief CompletedThis study compared a nerve block called an erector spinae plane (ESP) block to standard pain treatment for people with severe kidney stone pain. 24 adults took part. Researchers measured pain levels before and up to 60 minutes after treatment, and also tracked if extra pain medi…
Phase: PHASE4 • Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Nerve zapping for better sex? new study tests it.
Symptom relief CompletedThis study tested a treatment called percutaneous tibial nerve stimulation (PTNS) for women with sexual dysfunction. 79 women received either real PTNS or a fake version to see if it improved their sexual function. The goal was to find a non-drug option for this common problem.
Phase: NA • Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can learning to relax help Parkinson's patients and their caregivers?
Symptom relief CompletedThis study tested an 8-session stress management program for people recently diagnosed with Parkinson's disease and their caregivers. The program teaches relaxation techniques, healthy habits, and ways to change negative thinking. Researchers wanted to see if the program was prac…
Phase: NA • Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could an arthritis drug ease depression by calming brain inflammation?
Symptom relief CompletedThis study tested whether celecoxib (Celebrex), an anti-inflammatory drug, can reduce brain inflammation in people with major depression. 41 adults with depression received 400 mg of celecoxib daily for 8 weeks. Researchers used PET scans to measure inflammation before and after …
Phase: PHASE4 • Sponsor: Stony Brook University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC